| Bivalirudin for patients with acute coronary syndromes GW Stone, BT McLaurin, DA Cox, ME Bertrand, AM Lincoff, JW Moses, ... New England Journal of Medicine 355 (21), 2203-2216, 2006 | 1759 | 2006 |
| Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 … AM Lincoff, JA Bittl, RA Harrington, F Feit, NS Kleiman, JD Jackman, ... Jama 289 (7), 853-863, 2003 | 1480 | 2003 |
| Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY Trial SV Manoukian, F Feit, R Mehran, MD Voeltz, R Ebrahimi, M Hamon, ... Journal of the American College of Cardiology 49 (12), 1362-1368, 2007 | 1022 | 2007 |
| Liposomal amphotericin b as initial therapy for invasive mold infection: a randomized trial comparing a high–loading dose regimen with standard dosing (AmBiLoad Trial) OA Cornely, J Maertens, M Bresnik, R Ebrahimi, AJ Ullmann, E Bouza, ... Clinical infectious diseases 44 (10), 1289-1297, 2007 | 836 | 2007 |
| Long-term efficacy of bivalirudin and provisional glycoprotein IIb/IIIa blockade vs heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary … AM Lincoff, NS Kleiman, DJ Kereiakes, F Feit, JA Bittl, JD Jackman, ... Jama 292 (6), 696-703, 2004 | 492 | 2004 |
| Post-traumatic stress disorder, coronary atherosclerosis, and mortality N Ahmadi, F Hajsadeghi, HB Mirshkarlo, M Budoff, R Yehuda, R Ebrahimi The American journal of cardiology 108 (1), 29-33, 2011 | 271 | 2011 |
| Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY … KK Ray, HM Colhoun, M Szarek, M Baccara-Dinet, DL Bhatt, VA Bittner, ... The lancet Diabetes & endocrinology 7 (8), 618-628, 2019 | 267 | 2019 |
| Outcomes following pre-operative clopidogrel administration in patients with acute coronary syndromes undergoing coronary artery bypass surgery: the ACUITY (Acute … R Ebrahimi, C Dyke, R Mehran, SV Manoukian, F Feit, DA Cox, BJ Gersh, ... Journal of the American College of Cardiology 53 (21), 1965-1972, 2009 | 179 | 2009 |
| Association of subclinical hypothyroidism and cardiovascular disease with mortality K Inoue, B Ritz, GA Brent, R Ebrahimi, CM Rhee, AM Leung JAMA network open 3 (2), e1920745-e1920745, 2020 | 134 | 2020 |
| Mortality incidence of patients with non-obstructive coronary artery disease diagnosed by computed tomography angiography N Ahmadi, V Nabavi, F Hajsadeghi, F Flores, WJ French, SS Mao, ... The American journal of cardiology 107 (1), 10-16, 2011 | 123 | 2011 |
| Mitral annulus calcification is associated with valvular and cardiac structural abnormalities MR Movahed, Y Saito, M Ahmadi-Kashani, R Ebrahimi Cardiovascular Ultrasound 5, 1-4, 2007 | 117 | 2007 |
| Clevidipine, an intravenous dihydropyridine calcium channel blocker, is safe and effective for the treatment of patients with acute severe hypertension CV Pollack, J Varon, NA Garrison, R Ebrahimi, L Dunbar, WF Peacock IV Annals of emergency medicine 53 (3), 329-338, 2009 | 112 | 2009 |
| Impact of femoral vascular closure devices and antithrombotic therapy on access site bleeding in acute coronary syndromes: The Acute Catheterization and Urgent Intervention … TA Sanborn, R Ebrahimi, SV Manoukian, BT McLaurin, DA Cox, F Feit, ... Circulation: Cardiovascular Interventions 3 (1), 57-62, 2010 | 111 | 2010 |
| Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61): a randomised, placebo-controlled trial EA Bohula, BM Scirica, SE Inzucchi, DK McGuire, AC Keech, SR Smith, ... The Lancet 392 (10161), 2269-2279, 2018 | 93 | 2018 |
| Anticoagulation with otamixaban and ischemic events in non–ST-segment elevation acute coronary syndromes: the TAO randomized clinical trial PG Steg, SR Mehta, CV Pollack, C Bode, M Cohen, WJ French, ... Jama 310 (11), 1145-1155, 2013 | 90 | 2013 |
| Impact of chronic kidney disease on early (30-day) and late (1-year) outcomes of patients with acute coronary syndromes treated with alternative antithrombotic treatment … R Mehran, E Nikolsky, AJ Lansky, AJ Kirtane, YH Kim, F Feit, ... JACC: Cardiovascular Interventions 2 (8), 748-757, 2009 | 85 | 2009 |
| Safety and efficacy of bivalirudin monotherapy in patients with diabetes mellitus and acute coronary syndromes: a report from the ACUITY (Acute Catheterization and Urgent … F Feit, SV Manoukian, R Ebrahimi, CV Pollack, EM Ohman, MJ Attubato, ... Journal of the American College of Cardiology 51 (17), 1645-1652, 2008 | 84 | 2008 |
| Postoperative atrial fibrillation impacts on costs and one-year clinical outcomes: the Veterans Affairs Randomized On/Off Bypass Trial GH Almassi, TH Wagner, B Carr, B Hattler, JF Collins, JA Quin, ... The Annals of thoracic surgery 99 (1), 109-114, 2015 | 81 | 2015 |
| REPLACE-2 Investigators. Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous … AM Lincoff, JA Bittl, RA Harrington, F Feit, NS Kleiman, JD Jackman, ... Jama 289 (7), 853-863, 2003 | 81 | 2003 |
| Effects of intense exercise and moderate caloric restriction on cardiovascular risk factors and inflammation N Ahmadi, S Eshaghian, R Huizenga, K Sosnin, R Ebrahimi, R Siegel The American journal of medicine 124 (10), 978-982, 2011 | 76 | 2011 |
